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Abstract 
Skin disorders are often associated with immune and nervous system dysfunction. 
Intraepidermal nerve fibers (IENFs) detect mechanical, thermal, and noxious stimuli. Although 
immune cells such as mast and T cells can alter IENFs, it is unclear whether Langerhans cells 
(LCs), the resident antigen-presenting cell of the skin, do so as well. These studies examine the 
relationship between IENFs and LCs. 
LCs are intimately associated with IENFs, and in vitro studies suggest they possess 
neurotrophic properties. The objective of the first study was to determine if LCs regulate IENFs 
in skin by ablating LCs using diphtheria toxin in Lang-DTR mice, a strain genetically engineered 
to express the diphtheria toxin receptor selectively on LCs. In 1 month old mice, LC depletion 
resulted in 31% and 43% decreases in IENFs immunoreactive (ir) for the pan-neuronal marker 
PGP9.5 and calcitonin gene-related peptide (CGRP). CGRP-negative (non-peptidergic) IENFs 
were unchanged. Therefore, LCs are necessary for maintaining CGRP-ir IENFs. Since IENFs 
are modulated by neurotrophic factors, we determined if LC depletion results in reduced 
epidermal neurotrophin gene expression. LC depletion decreased NGF and GDNF gene 
expression by roughly 75% and 90%, respectively whereas BDNF did not change. Thus, LCs 
are likely to play a substantial role in epidermal NGF and GDNF production, and loss of CGRP-
ir IENFs after LC depletion is likely due to diminished trophic support. Behavioral testing was 
performed to determine if LC depletion alters thermal and mechanical sensitivity.  LC depletion 
increased mechanical sensitivity but did not affect thermal sensitivity. Therefore, LCs play an 
essential role in maintaining CGRP-ir IENFs and determining mechanical sensitivity in 1 month 
old mice. 
Because age can alter LCs and IENFs, we examined LCs and IENFs in 10 month old 
control and LC-depleted mice. LC and PGP9.5-ir IENF numbers were reduced in older mice. LC 
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depletion further reduced PGP9.5-ir IENF density by 52%. Numbers of CGRP-ir IENFs did not 
change, but LC depletion reduced non-peptidergic IENFs by 98%. This implies that LCs exert 
age-dependent influences on different IENF subtypes, changing from CGRP-ir to non-
peptidergic with age. LC depletion did not alter NGF, GDNF or BDNF gene expression in older 
mice. LCs therefore play a major, age dependent role in determining cutaneous innervation 
density, neurotrophic factor expression, and mechanical sensitivity.  
Neuro-immune cell interactions are altered in individuals with diabetes, which may 
contribute to cutaneous complications. The objective of the second study was to determine if the 
relationship between LCs and IENFs is altered in the rat with streptozotocin-induced diabetes. 
Footpad LC density was reduced after 4 weeks of diabetes, and LC density and size were 
reduced at 16 weeks. We examined if age influenced LCs and IENFs and found the proportion 
of skin occupied by LCs was increased by 141%, while IENFs were reduced by 37% in older 
rats. The increase in cutaneous LCs with age may have occurred in response to IENF 
reductions. PGP9.5-ir IENFs were not affected by diabetes in our rats; however, reductions in 
LCs apparently preceded nerve reductions reported by others at later times. Overall, this study 
shows that diabetes reduces LCs, which may lead to decreased immunosurveillance and 
increased susceptibility to infections, as well as reduced innervation in the later stages of 
diabetes.  
Collectively, these data show that LCs are essential in maintaining cutaneous 
innervation. They appear to play a major, previously unidentified role in determining cutaneous 
neurotrophin production, shedding light on a new function for these classical ‘immune’ cells.  
Their importance is underscored by the finding that eliminating LCs substantially reduces 
cutaneous innervation.  Moreover, this is functionally significant given that mice showed 
pronounced mechanical hypersensitivity after LC depletion.  Interestingly, this nerve loss and 
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allodynia are quite reminiscent of the clinical picture in many types of peripheral neuropathies.  
Further, the findings that LCs are altered by both diabetes and aging is consistent with the idea 
that factors that contribute to neuropathies also alter LCs.  Clearly, additional study is warranted 
to further define the roles of these neuro-immune cells in regulating peripheral innervation. 
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Nerve-immune cell interaction exists and can be a factor in various disorders 
Nerve-immune cell relationship in the central nervous system 
In the past century, scientist have shown that not only do neurons and immune cells 
have their own distinct function, but these cells are able to interact with each other. Also, this 
interaction appears to be essential for daily functions throughout the body. With respect to the 
central nervous system which is composed of the brain and spinal cord, experiments reveal 
neurotransmitters and neuropeptides such as glutamate, norepinephrine, and vasoactive 
intestinal peptide can decrease immune responses within brain tissue (Neumann, 2001; Tian et 
al., 2009). Neurotrophic factors such as nerve growth factor and brain-derived neurotrophic 
factor can reduce immune function in vitro (Neumann, 2001). Also, pro-inflammatory cytokines 
released by immune cells can negatively modulate neurogenesis in the brain (Carpentier and 
Palmer, 2009).  
In addition to the discovery of crosstalk between nerves and immune cells, an imbalance 
between these cells can be a factor for many neurodegenerative disorders. For example, 
inflammation is thought to contribute to the pathogenesis of multiple sclerosis, Parkinson’s 
disease, and Alzheimer’s disease (Tian et al., 2009; Cameron and Landreth, 2010; Chung et al., 
2010; Wilson et al., 2010). Pro-inflammatory cytokines released by immune cells in addition to 
activated microglia (the brain’s resident macrophage) can contribute to tissue damage in 
response to brain injury or stroke (Tian et al., 2009). These data suggest that crosstalk does 
exist between immune cells and the central nervous system and that this interaction must be 
balanced for proper immune and neural function. 
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Nerve-immune cell relationship in the peripheral nervous system 
 Autonomic 
Interaction is also identified between the peripheral nervous system and immune cells. 
The peripheral nervous system is defined as the neurons and their axons outside of the central 
nervous system. The peripheral nervous system is divided into two groups: autonomic and 
somatic sensory. The purpose of the autonomic nervous system is to control involuntary 
functions such as breathing, digestion, and circulation. Research shows that the thymus, 
spleen, and bone marrow (all of which produce immune cells) are innervated by sympathetic 
nerve fibers, an autonomic nerve fiber subtype (Friedman and Irwin, 1997; Bellinger et al., 
2008). Activation of sympathetic nerve fibers reduces immune cell proliferation in vivo (Pezzone 
et al., 1992; Friedman and Irwin, 1997).   
Abnormalities in the relationship between the autonomic nervous system and immune 
cells have been linked to various disorders. For example, irritable bowel syndrome may be 
associated with inflammation-induced chronic excitation of enteric neurons, a subset of the 
autonomic nervous system (Lakhan and Kirchgessner, 2010). Our own laboratory has shown 
that immune cell infiltration after myocardial infarction can cause sympathetic hyperinnervation 
(Wernli et al., 2009). One topic that is gaining more attention, with respect to the autonomic 
nervous system, is the correlation between the extent to which a person is psychologically 
stressed and the intensity of an immune response (Irwin, 2008). Researchers hypothesize that 
changes in behavior can activate the autonomic nervous system which in turn decreases 
immunity (Irwin, 2008). Although most research is focused on neural influences on immune 
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cells, data show communication exists between the immune and autonomic nervous systems. 
Furthermore, crosstalk can be a modulator of immune function.  
Somatic Sensory 
Neurons of the somatosensory nervous system function to recognize thermal, 
mechanical, and painful stimuli and send information about said stimuli to the brain. Once 
processed, the brain in turn sends signals in an efferent direction to muscles to perform an 
action. With respect to nerve-immune cell interaction, bone marrow, spleen, and thymus are all 
innervated by sensory nerves that contain neuropeptides such as calcitonin gene-related 
peptide, vasoactive intestinal peptide, and substance P (Fink and Weihe, 1988; Weihe et al., 
1989; Weihe et al., 1991).  Studies reveal neuropeptides can reduce immune cell proliferation 
and function (Bulloch et al., 1995; Fox et al., 1997; Rochlitzer et al., 2011). Although the 
purpose is unclear, regulation of immune cell proliferation and function in normal tissue may be 
part of a feedback loop that prevents chronic inflammation.  
Cutaneous disorders affect 1 in 3 individuals (Bickers et al., 2006). This can include 
psoriasis, dermatitis, acne, ulcers and infections. Annually, the United States spends billions of 
dollars to treat skin disorders (Bickers et al., 2006; Basra and Shahrukh, 2009). With respect to 
the epidermis of skin, crosstalk between nerves and immune cells is increasingly being 
recognized as a factor for cutaneous disorders. For example, inflammation associated with 
atopic dermatitis, psoriasis, and eczema is thought to be linked to hyperinnervation of sensory 
fibers (Chan et al., 1997; Jarvikallio et al., 2003; Tokime et al., 2008). Since immune cells can 
produce neurotrophins (Caroleo et al., 2001; Raap and Kapp, 2010; Yoshimura et al., 2010) and 
secrete cytokines that promote neurotrophin production through keratinocytes (Blasing et al., 
2005), these data suggest immune cells may be inducing hyperinnervation. Taken together, the 
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relationship between the immune and nervous systems plays a role in nerve and immune cell 
status. Also, with respect to the pathogenesis of neurological and inflammatory disorders, this 
interaction is gaining more attention as a significant contributor to disease progression.  
Components of the epidermis 
Skin is the largest and one of the most important organs of the body. A major function of 
the skin is to protect our internal organs from external antigens and pathogens while providing 
information about various external stimuli. The epidermis, one of the components of skin, is the 
first line of defense against harmful pathogens and is often the site of abnormalities in nerve-
immune cell interaction. In order to develop drugs that alleviate cutaneous complications 
associated with abnormal nerve-immune cell interactions, it is necessary to understand the cells 
that make up the epidermis and their function. Structurally, the epidermis has five layers: 
stratum corneum, stratum lucidum, stratum granulosum, stratum spinosum, and stratum basale. 
The epidermis is composed of cells such as keratinocytes, melanocytes, merkel cells, and 
migratory immune cells (Loser and Beissert, 2007; Boulais and Misery, 2008). Keratinocytes 
make up roughly 80% of the cells within the epidermis. Keratinocytes possess many functions 
within the skin such as providing growth factors for immune cells and nerve fibers (McKenzie 
and Sauder, 1990a; Boulais and Misery, 2008). In addition, they secrete many stimulatory 
factors which are necessary for immune responses and injury-induced inflammation (McKenzie 
and Sauder, 1990b).   
Migratory immune cells such as macrophages, mast cells, neutrophils, T cells, and 
Langerhans Cells (LCs) can all be found in the epidermis (Loser and Beissert, 2007). Generally, 
these cells (except for LCs) are only found in the epidermis in response to foreign antigen 
invasion or inflammation associated with injury and wound healing (Cooper et al., 1993). 
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Macrophages, mast cells, neutrophils, and T-cells are phagocytic leukocytes. When an immune 
response occurs, these cells become activated and migrate to the site of the invasion to clear 
the region of foreign antigens. These immune cells also play an essential role in inflammation 
which is critical for proper wound healing (McKay and Leigh, 1991; Pradhan et al., 2009). 
Altogether, migratory immune cells play an important role in the overall function of the skin. 
The epidermis is also innervated by intraepidermal nerve fibers (IENFs).  IENFs are the 
sensory free nerve endings of axons that extend from the dorsal root ganglion and terminate in 
the epidermis (Jankowski and Koerber, 2010). These fibers are essential for recognizing 
external stimuli such as mechanical, thermal, and pain and sending information to the brain 
(Lumpkin and Caterina, 2007; Montano et al., 2010). IENFs are categorized into two subtypes: 
C and A-delta fibers. C fibers are unmyelinated slow-conducting fibers while A-delta fibers are 
finely myelinated and have an intermediate conduction rate (Jankowski and Koerber, 2010; 
Montano et al., 2010). Since they are activated by various stimuli, C and A-delta fibers are 
considered polymodal. C fibers can be further divided into two subtypes: peptidergic and non-
peptidergic fibers. Peptidergic fibers secrete peptides such as calcitonin gene-related peptide, 
substance P, and vasoactive intestinal peptide (Karanth et al., 1991). Fibers that do not produce 
or secrete peptides (non-peptidergic) express isolectin-B4 (Gerke and Plenderleith, 2001).  In 
terms of growth factors, peptidergic IENFs are highly responsive to nerve growth factor whereas 
non-peptidergic fibers are highly responsive to glial cell line-derived neurotrophic factor (Akkina 
et al., 2001; Montano et al., 2010). Overall, the epidermis is composed of different IENF subsets 
which allow the brain to distinguish various stimuli.  
 
Intraepidermal nerve fiber and immune cells have a bi-directional crosstalk  
7 
 
Neuro-immune cell interaction has proven to be an essential part of inflammation 
associated with immune responses and injury in the skin. In 1919, scientists first showed 
inflammation induced by mustard oil application was reduced in denervated human skin 
(Breslauer, 1919; Jancso et al., 1967). Since then, numerous studies revealed that 
neuropeptides released by IENFs play a significant role with respect to inflammation. In 
addition, neurogenic inflammation is suggested to be critical component of wound healing 
(Pradhan et al., 2009). IENFs can also influence the intensity of an immune response (Steinhoff 
et al., 2003). A contact hypersensitivity model showed that after topical application of capsaicin 
the immune response was reduced (Beresford et al., 2004). Since capsaicin is known to deplete 
IENFs of neuropeptides, this suggests that neuropeptide are necessary for proper immune 
responses. When examining the effect of immune cells on IENFs, majority of research 
concentrates on macrophages, T cells, or mast cells. However, little is understood about the 
relationship between IENFs and LCs, the resident antigen presenting cells of the skin, and 
whether LCs influence IENFs.  
 
Langerhans Cells 
LCs were first discovered 143 years ago by Paul Langerhans (Langerhans, 1868). While 
making up only 2-3% of the epidermal cell population, these cells were first thought to be the 
intraepidermal nerve receptors (Jolles, 2002). Over a century later, researchers found that LCs 
were not neuronal receptors but possessed a phenotype similar to immune cells (Silberberg, 
1973). Although LCs are present within stratified squamous epithelium of the oral cavity, vagina, 
esophagus, and cornea, (Rowden, 1967, 1981; Iijima et al., 2007) most information obtained 
about these cells is extrapolated from research pertaining to the epidermis.  
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LCs are thought to be involved in both the innate and adaptive immune response (de 
Jong and Geijtenbeek, 2010). In both cases, LCs can be activated by foreign antigens and/or 
co-stimulatory signals released by nearby keratinocytes (McKenzie and Sauder, 1990b). Upon 
activation, these cells endocytose foreign antigens and travel to nearby cutaneous lymph nodes 
where they present antigens to T cells. In response, T cells will travel to the site where the 
antigen was recognized and destroy the cells that express the foreign antigen (adaptive) or 
create memory T cells for any subsequent exposure to the same antigen (innate). 
Under steady-state conditions, LCs are derived from haematopoietic precursor cells 
(Merad et al., 2008). However, research has also shown that under inflamed states circulating 
monocytes can modify their phenotype to that of LCs (Merad et al., 2008). LCs are distinguished 
from other immune cells by the presence of langerin and Birbeck granules (Merad et al., 2008). 
Langerin is a type II Ca2+-dependent lectin (Valladeau et al., 1999; Valladeau et al., 2000; 
Romani et al., 2010). Langerin act as a “receptor” that binds to mannose expressing cells. Upon 
recognition, the ligand bound lectin is internalized for processing. Once processed, the cell 
presents small portions of the antigen with the use of the major histocompatibility complex II to T 
cells.  Birbeck granules are a “tennis racket” like structure that are thought to be involved in 
antigen processing (Merad et al., 2008). These data suggests LCs play a critical role in the 
skin’s immune response system and potentially in injury-induced inflammation. A reduction in 
LCs may likely contribute to increased susceptibility to severe infections. 
 
Crosstalk exists between Langerhans cells and intraepidermal nerve fibers 
Most of the research available about LC-IENF interaction is focused on the effects of 
nerves on LCs. Many studies using different rat models have shown IENF degeneration 
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increases LC status in the epidermis (Hsieh et al., 1996; Lauria et al., 2005b). One study also 
revealed that LC status decreased once IENFs regenerate after nerve injury (Hsieh et al., 
1996). Furthermore, LCs express neuropeptide receptors and upon binding decreases antigen 
presentation (Kodali et al., 2004; Ding et al., 2007). Given the role of LCs, these results suggest 
that a balance must be kept between LCs and IENFs for proper immune function.  
Immune cells possess the ability to provide support for neurons (Vega et al., 2003; 
Lambiase et al., 2004; Kruse et al., 2007; Ralainirina et al., 2010). Although LC-like cells were 
able to cause PC12 cells to differentiate into neuronal-like cells in vitro (Torii et al., 1997), little is 
understood about whether LCs provide neurotrophic support in vivo. Within the epidermis, LCs 
are often in close proximity to and even appear to physically contact IENFs (Hosoi et al., 1993; 
Chateau and Misery, 2004). This physical arrangement could provide not only a way for IENFs 
to influence LCs but could also offer a way for LCs to promote IENF growth or alter IENF 
function. Therefore, the objective of the first study was to determine whether LCs influence 
IENFs in a LC depletion mouse model.  
 
Nerve-immune cell interaction may be a factor in cutaneous complications associated 
with Diabetes Mellitus 
Diabetes mellitus (DM) affects hundreds of million people worldwide of which over 20 
million reside in the United States (Shaw et al., 2010). DM is characterized as a deficiency in 
insulin production, insulin action or both. If uncontrolled, DM can be a severely debilitating 
disease (Meijer et al., 2001). The American Diabetes Association states DM can lead to 
complications such as heart disease, stroke, high blood pressure, dental disease, kidney 
disease, blindness, complications with pregnancy, amputations, and neuropathy. With respect 
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to skin, common cutaneous complications associated with DM are small fiber neuropathy, 
cutaneous ulcers, and severely infected cutaneous wounds (Ferringer and Miller, 2002; Xie et 
al., 2010). Data reveal that contributing factors for the development of these complications can 
be ischemia, oxidative stress, an imbalance in the immune system, and reduction in 
neurotrophin expression within the epidermis (Zochodne, 2007). Although many factors 
contribute to the progression of diabetes-induced cutaneous complications, we are still unable 
to create therapeutic drugs that completely alleviate or prevent these issues. Since irregular 
nerve-immune cell interaction appears to be a factor for many cutaneous disorders, it is 
reasonable to hypothesize that abnormal nerve-immune cell interactions may also be a factor in 
diabetes-induced cutaneous complications. More specifically, the interaction between LCs and 
IENFs may prove to be a factor in the progression of cutaneous complications associated with 
diabetes. Therefore, the objective of the second study is to examine the relationship between 
LCs and IENFs in streptozotocin-induced diabetic rat. 
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Chapter 2: Langerhans Cells Regulate Cutaneous Innervation and Mechanical 
Sensitivity in the Mouse Footpad 
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Abstract 
Intraepidermal nerve fibers are essential for detecting noxious and non-noxious stimuli. 
Since several disorders are associated with cutaneous axon degeneration, it is important to 
elucidate factors responsible for maintaining innervation. In vitro data suggest Langerhans cells, 
a major cutaneous antigen-presenting immune cell, produce neurotrophic factors, but it is 
unclear whether they contribute to skin innervation in vivo. We depleted Langerhans cells in 
Lang-DTR mice by diphtheria toxin administration and assessed cutaneous innervation, 
epidermal neurotrophin gene expression, and thermal and mechanical sensitivity in footpads.  
Following LC depletion, overall innervation immunoreactive for PGP9.5 was reduced by 28% in 
mice at 1 month of age. Axons immunoreactive for calcitonin gene-related peptide were also 
reduced by 43%, while immuno-negative axons were unaffected.  In isolated epidermal sheets 
of LC-depleted mice, NGF and GDNF gene expression were markedly diminished, while BDNF 
was unchanged.  Mice exhibited mechanical hypersensitivity, although thermal sensitivity was 
not altered. LC depletion at 10 months of age resulted in greater loss of PGP9.5-
immunoreactive axons, due to selective depletion of axons immuno-negative for CGRP. 
Neurotrophin gene expression was unchanged at this age. These findings show LCs play a 
major role in regulating cutaneous neurotrophin gene expression and are critical in determining 
cutaneous innervation density and sensitivity in an age-dependent manner.  Disturbances in 
LCs may therefore contribute to neurological dysfunction in peripheral neuropathies. 
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Introduction 
Intraepidermal nerve fibers (IENFs) are sensory nerve endings of dorsal root ganglia that 
terminate in the epidermis (Lauria et al., 2009). Their function is to identify tactile, thermal, and 
noxious stimuli (Lumpkin and Caterina, 2007; Lauria et al., 2009), but they are important also for 
injury-induced inflammation (Steinhoff et al., 2003) and the skin’s immune response to foreign 
antigens (Shepherd et al., 2005). Taken together, the multiple functions of IENFs make them a 
critical component of the skin. However, with the progression of certain disorders, such as 
diabetes (Lacomis, 2002; Hsieh, 2010), Guillain-Barré syndrome (Pan et al., 2003), and 
HIV/AIDS (Polydefkis et al., 2002), IENF degeneration can occur.  
Mechanisms involved in maintaining IENFs remain unclear. Research shows that 
keratinocytes, a primary cell of the epidermis, produce neurotrophic factors (NTFs) (Di Marco et 
al., 1991; Yaar et al., 1991; Grewe et al., 2000; Marconi et al., 2003; Tokime et al., 2008; 
Montano et al., 2010; Truzzi et al., 2011). Overexpression of NTFs in keratinocytes increases 
IENFs suggesting that keratinocytes may be responsible for regulating IENFs. 
However, keratinocytes are not the only cell in the epidermis that produce NTFs. 
Melanocytes, representing 5-10% of epidermal cells (Holbrook et al., 1988), also synthesize 
neurotrophic factors (Marconi et al., 2006). In addition, an in vitro study using a LC-like cell line 
suggests LCs produce NTFs (Torii et al., 1997). Langerhans cells (LCs) are considered the 
resident antigen-presenting cells of the epidermis (Ayala-Garcia et al., 2005). LCs capture 
foreign antigens and travel to regional lymph nodes where they present antigens to T cells, thus 
participating in innate and adaptive immune responses (Lore et al., 1998; Ayala-Garcia et al., 
2005; de Jong and Geijtenbeek, 2010; Ginhoux and Merad, 2010). LCs are distinguishable from 
other epidermal cells by their ability to express langerin (Valladeau et al., 1999; Romani et al., 
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2010) which is thought to be involved in ligand internalization and antigen presentation 
(Valladeau et al., 2000; Merad et al., 2008). There is reason to believe that LCs interact with 
IENFs. LCs make intimate contacts with IENFs (Hosoi et al., 1993; Gaudillere et al., 1996),and  
epidermal innervation appears to influence LC density (Hsieh et al., 1996; Stankovic et al., 
1999; Siau et al., 2006; Jin et al., 2008). However, a role of LCs in epidermal innervation has 
not been explored. The objective of this study was to determine if LCs influence IENF density 
and their ability to respond to mechanical and thermal stimuli. 
Materials and Methods 
All animal protocols were approved by the University of Kansas Medical Center’s 
Animals Care and Use Committee, and in accordance with the National Institute of Health 
guidelines for the care and use of laboratory animals. 
Lang-DTR mice express the human diphtheria toxin receptor (DTR) fused to enhanced 
green fluorescent protein (eGFP) under the control of the langerin gene (Kissenpfennig et al., 
2005). This allowed us to visualize and monitor LCs under various conditions and to temporarily 
deplete the skin of LCs by administering DT (Kissenpfennig et al., 2005; Bassett et al., 2011). 
We used Lang-DTR mice (a kind gift from Dr. Bernard Malissen) to examine the role of LCs in 
maintaining epidermal innervation in 1 and 10 month old mice.  
DT Administration 
LC depletion was accomplished by administering intraperitoneal injections of DT (1µg in 
100µl, (Kissenpfennig et al., 2005)) (Sigma Aldrich, St. Louis, MO) or vehicle (water) on day 0 
(first injection day), 4, 8, and 12. Mice were 1 or 10 ± 1 month old when the experiment began. 
Twenty-three C57BL/6 (Jackson Laboratories, Sacramento, CA) and twenty-three Lang-DTR 
mice were used for this study. 
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Thermal and Mechanical Sensitivity 
Thermal and mechanical sensitivity were measured one day prior to treatment and on 
post-injection days 1 and13.  Animals were placed upon a glass surface and allowed to 
acclimate for 30 minutes prior to thermal testing. Testing consists of a radiant heat source 
applied to the plantar surface of the hind paw, and time in seconds required for the animal to 
withdraw its paw (latency) is recorded. Thermal sensitivity was measured with a PAW Thermal 
Stimulator (4.3A; University of California San Diego, San Diego, CA). Each animal was tested 3 
times on each hind paw with 5-10 minutes between each test.  
After thermal testing, animals were placed upon a wire mesh platform and acclimated for 
30 minutes before testing. An electronic von Frey apparatus (IITC Life Science, Woodland Hills, 
CA) was used to assess mechanical sensitivity by applying pressure to the hind paw with a 
monofilament.  Pressure in grams required for the mouse to withdraw its paw was recorded. 
Each animal was tested 3 times with 5-10 minutes between tests.    
Quantitative reverse transcription polymerase chain reaction  
Quantitative reverse transcription polymerase chain reaction was performed to assess 
epidermal gene expression of nerve growth factor (NGF), brain-derived neurotrophic factor 
(BDNF), and glial cell line-derived neurotrophic factor (GDNF). On post-injection day 14, mice 
receiving DT or vehicle were anesthetized with isofluorane (Abbott Animal Health, Abbott Park, 
IL).The left hind paw footpad was excised and placed in 20mM EDTA for 1 hour at 37°C. 
Epidermal sheets were removed and rinsed in cold 0.1M phosphate buffered saline (PBS) for 5 
minutes, frozen on dry ice, and stored at -80°C for mRNA extraction or immunostaining.  
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Total RNA was extracted in TRIzol (Invitrogen, Carlsbad, CA). Total RNA concentrations 
were measured using a NanoDrop ND-1000 spectrophotometer (ThermoScientific, Rockford, 
IL). To form complimentary DNA, 1µg of mRNA was used along with SuperScript II Reverse 
Transcriptase (Invitrogen, Carlsbad, CA) and MJ Mini Personal Thermal Cycler (BioRad, 
Hercules, CA). cDNA was amplified using iQ SYBR Green Supermix (BioRad, Hercules, CA) 
and an iCycler iQ Multicolor Real-Time PCR detection system (BioRad, Hercules, CA). Cycle 
number was recorded with the iCycler program (BioRad, Hercules, CA). Primer sets are: NGF, 
sense: TTTAAGAAACGGAGACTC and anti-sense: CTGTTGAAAGGGATTGTA; BDNF, sense:  
AGAGTGATGACCATCCTT and anti-sense: TGGACGTTTACTTCTTTCA; GDNF, sense: 
TTAACTGCCATACACTTA and anti-sense: CTACTTTGTCACTTGTTAG.  For quantitation, 
glyceraldehyde 3-phosphate dehydrogenase was used as a housekeeping gene: sense: 
CTCTACCCACGGCAAGTTC and anti-sense: CTCAGCACCAGCATCACC (Integrated DNA 
Technologies, Coralville, IA). 
Immunohistochemistry 
Right hind paws were fixed in Zamboni’s solution for 24 hours, rinsed daily in PBS for 14 
days, immersed in 30% sucrose for 3-5 days, frozen in tissue freezing medium (Electron 
Microscopy Sciences, Hatfield, PA), and stored at -80˚C. Footpads were serially sectioned at 20 
µm in sagittal orientation. Sections were stored at -80˚C prior to staining.  
Sections were treated with 100mM glycine in PBS for 30 minutes followed by a 20 
minute rinse in PBS and a 1 hour immersion in superblock buffer (ThermoScientific, Rockford, 
IL). Tissue was stained overnight with primary antisera for protein gene product 9.5 (PGP9.5) 
(1:800, rabbit IgG, AbD Serotec, Raleigh, NC), calcitonin gene-related peptide (CGRP) (1:600, 
sheep IgG, Enzo Life Sciences, Farmingdale, NY), langerin (1:800, goat IgG Santa Cruz 
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Biotechnology, Santa Cruz, CA). After rinsing in PBS with 3% triton for 30 minutes, tissue was 
incubated with  Cy3 conjugated donkey anti-goat (1:200), Cy3 conjugated donkey anti-rabbit 
(1:800), Alexa 488 conjugated donkey anti-rabbit(1:600), Cy3 conjugated donkey anti-
sheep(1:400), or Cy2 conjugated donkey anti-goat IgG secondary antibodies (1:200) (Jackson 
ImmunoResearch Laboratories, Inc., West Grove, PA) for one hour. Sections were rinsed for 20 
minutes in PBS and coverslipped with Fluoromount G. Three sections at 240μm intervals were 
analyzed per animal. 
Epidermal Nerve Fiber Quantification  
A method adopted by European Federation of Neurological Societies (Lauria et al., 
2005a) was used to quantify IENFs. Individual IENFs crossing the dermal-epidermal junction 
were counted, excluding any secondary branching. Counts were divided by the length of the 
epidermis and expressed as IENF/mm. Three regions spaced equidistantly along the length of 
each section were selected, providing an index of innervation at the distal, middle, and proximal 
regions of the footpad. A 40X objective and 10X eyepiece on a Nikon Eclipse TE300 inverted 
microscope (Nikon Corp., Tokyo, Japan) was used to visualize IENFs. Each region spanned 
0.42mm. To determine epidermal length for each region, images were taken and the basement 
membrane was measured. PGP9.5, a pan-neuronal marker (Wang et al., 1990), was used to 
identify both peptidergic and non-peptidergic IENFs. CGRP is a marker for peptidergic IENFs 
(Vaalasti et al., 1988) and was used to determine changes in CGRP-ir peptidergic IENFs. To 
determine non-peptidergic IENF density, CGRP-ir IENF density was subtracted from PGP9.5-ir 
IENF density. Non-peptidergic IENFs are referred to as CGRP-negative (-). Epidermal thickness 
was determined by measuring the height of the epidermis within the center of each image.    
LC analysis in the footpad 
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To determine LC status in the epidermis, Z-stacks of confocal microscopic images of 
langerin immunoreactivity were captured at the distal, middle, and proximal regions each 
section with a 40X oil immersion objective on an Eclipse 90i microscope equipped with a Nikon 
C1si confocal system and a D-Eclipse camera (Melville, NY). Image renderings were created 
using maximum projection on volume renderings of Z-stacks using Nikon EZ-C1 FreeViewer 
(Melville, NY). Each image was calibrated and analyzed with Metamorph analysis program. 
LC density was measured by dividing the number of LCs by the epidermal area (µm2). 
Epidermal area was quantified by tracing around the epidermis, while excluding the stratum 
corneum layer. Research suggests LC size may be an indicator of functional maturity (Nishibu 
et al., 2006). For this reason, we measured LC size. Size was determined by dividing the 
langerin-ir area (µm2) within the epidermis, measured by thresholding, by the number of LCs. To 
determine the percent of epidermal area occupied by LCs, langerin-ir area was divided by the 
epidermal area and multiplied by 100. 
Statistical Analysis 
Epidermal thickness, LC density, size, the percent epidermal area occupied by LCs, 
IENF density, and gene expression was analyzed statistically by t-test or two way analysis of 
variance and Student-Newman-Keuls post-hoc analysis. Behavioral data was analyzed using 
two way repeated measures analysis of variance and Student-Newman-Keuls post-hoc 
analysis. Differences were considered significant if p value was ≤0.05. Data are expressed as 
Mean ± Standard Error Mean (SEM). 
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Results 
Diphtheria toxin does not affect LCs in C57BL/6 mice  
We confirmed that DT, a foreign antigen and potential toxin, does not affect skin and 
innervation in normal mice. DT did not affect epidermal thickness (Table 1), nor did it alter LC 
density, size, or the % of epidermal area occupied within 1 or 10 month old mice (Figure 1).DT 
had no effect on PGP9.5-ir (Figure 2a-b and i), CGRP-ir (Figure 2c-d and j), and non-peptidergic 
(Figure 2k) innervation of 1 month old C57BL/6 mice. However, in 10 month old mice, DT 
reduced PGP9.5-ir IENFs by 22% (p=0.007, Figure 2e-f and i), without a detectable effect on 
peptidergic or non-peptidergic fibers (Figure 2g-h and j-k).  
LC depletion reduces IENF density  
DT administration to Lang-DTR mice depleted LCs in the footpad, as previously 
described for ear (Kissenpfennig et al., 2005). Langerin-ir LCs were present in the epidermis of 
vehicle-treated Lang-DTR mice (Figure 3a-c) but absent after DT treatment (Figure 3d-f).  LC 
depletion did not affect epidermal thickness in 1 and 10 month old Lang-DTR mice (Table 1). 
To determine if LC depletion alters cutaneous innervation, IENF density was quantified.  
LC depletion in 1 month old Lang-DTR mice, caused a 28% decrease in PGP9.5-ir IENF density 
(p= 0.036, Figure 4a, b, and e). LC depletion reduced CGRP-ir IENFs by 43% (p=0.045, Figure 
4c-e), while non-peptidergic IENF density was unchanged (Figure 4e). 
Langerhans cells and intraepidermal nerve fibers are reduced in older Lang-DTR mice 
Aging is associated with reductions in LC content (Bhushan et al., 2002; Cumberbatch et 
al., 2002) which may be a confounding factor when determining their role in maintaining IENFs. 
Accordingly, we assessed whether LCs were altered in older vehicle-treated mice. LC density 
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was reduced by 31% in older mice (677 ± 65 vs. 465 ± 21 # of LCs/mm2 in 1 and 10 month old 
mice, respectively) (p=0.022, Figure 5a and b). There was no significant change in LC size (185 
± 18 vs. 182 ± 8 µm2/# of LCs, Figure 5) or the % of epidermal area occupied by LCs (10 ±1 vs. 
8 ± 1%, Figure 5). Also, age did not affect epidermal thickness in vehicle-treated Lang-DTR 
mice (Table 1). 
IENFs are also reported to decrease with age (Goransson et al., 2004; Lauria et al., 
2010). PGP9.5-ir IENF density was reduced by 28% in older vehicle-treated mice (p=0.021, 
Figure 4a and 6a). CGRP-ir fibers tended to be lower in older vehicle-treated mice, although this 
did not achieve statistical significance (p=0.058, Figure 4c and 6c). Non-peptidergic IENF 
density was unchanged.  
IENF loss after LC depletion is greater in older mice 
We examined if IENF loss after LC depletion was altered in older mice. There appeared 
to be fewer PGP9.5-ir IENFs in LC-depleted mice at 10 months of age (Figure 6b). Quantitative 
analysis revealed a 52% decrease in PGP9.5-ir IENF density after DT administration (p<0.001, 
Figure 6e) which was significantly greater than the reduction seen in 10 month old DT-treated 
C57BL/6 mice (p<0.001). When compared to 1 month old mice, PGP9.5-ir IENFs were reduced 
by 52% (p=0.001, Figure 4e and 6e). CGRP-ir IENFs were not altered by LC depletion in 10 
month old mice (Figure 4c-e), and, there was no difference in CGRP-ir IENF density between 1 
and 10 month old LC-depleted mice (Figure 4d and 6d). However, LC depletion caused a 98% 
decrease in non-peptidergic IENFs at 10 months (p=0.007, Figure 6e). When compared to 1 
month old LC-depleted mice, 10 month old  mice lacking LCs  had a 98% reduction in non-
peptidergic IENFs (p=0.014, Figure 4e and 6e). 
Changes in epidermal neurotrophic factor gene expression after LC depletion 
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To determine if IENF loss after LC depletion is accompanied by reductions in NTF gene 
expression, we analyzed epidermal sheets of 1 and 10 month old mice using quantitative 
reverse transcription polymerase chain reaction (Figure 7). The epidermis is known to produce 
BDNF, NGF, and GDNF which influence large sensory (LeMaster et al., 1999), small peptidergic 
(Donnerer et al., 1996; Rice et al., 1998), and small non-peptidergic fibers (Akkina et al., 2001; 
Adly et al., 2006), respectively. No significant change in BDNF expression was observed with 
LC depletion in 1 month old Lang-DTR mice (Figure 7a). However, NGF (Figure 7b) and GDNF 
(Figure 7c) gene expression were reduced (p=0.012 and p=0.015, respectively). The fold 
reduction implies that LC depletion results in roughly a 75% loss of NGF and 90% GDNF gene 
expression at 1 month. However, NTF gene expression was not altered in 10 month old LC-
depleted Lang-DTR mice (Figure 7a-c), and DT did not affect NTF gene expression in C57BL/6 
mice (data not shown). 
Allodynia occurs after LC depletion  
Abnormal sensitivity occurs in many cutaneous disorders associated with nerve loss (Lin et al., 
2001; Johnson et al., 2008; Ward et al., 2011). Since LC depletion resulted in IENF loss, we 
assessed whether mechanical (Figure 8) and thermal sensitivity was altered. We observed no 
differences in mechanical sensitivity at baseline and post-injection day1and 13 within vehicle- or 
DT-treated C57BL/6 mice (Figure 8a). Also, DT did not alter mechanical sensitivity in C57BL/6 
mice. Analysis showed mechanical sensitivity was not altered in vehicle-treated Lang-DTR 
mice. However, LC-depleted mice exhibited increased mechanical sensitivity at day 13 when 
compared to pre-injection controls and all other groups at post-injection day13 (p<0.001). 
Vehicle- and DT-treated C57BL/6 and Lang-DTR mice did not exhibit any changes in thermal 
sensitivity (data not shown). 
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Discussion 
Many cell types influence epidermal innervation. This includes keratinocytes which 
produce a variety of neurotrophic factors. If overexpressed, these factors can result in 
hyperinnervation. In addition, immune cells, which are critical for immune responses and 
promoting inflammation, produce neurotrophic factors and cytokines that can modulate 
innervation (Caroleo et al., 2001; Blasing et al., 2005; Raap and Kapp, 2010; Yoshimura et al., 
2010). Until now, LCs are generally seen as antigen-presenting cells involved in innate and 
adaptive immune responses. It is with the use of Lang-DTR mice, we show that LC depletion 
induced by DT administration causes IENF loss resulting in a new role for LCs as a regulator of 
epidermal innervation.  
IENFs, which can be divided into C and A-δ fibers, detect thermal, mechanical, and 
noxious stimuli. C fibers are further categorized as peptidergic and non-peptidergic. Since these 
fibers detect multiple stimuli, they are considered polymodal (Perl, 1996). A reduction in a 
specific fiber subtype may explain changes observed in cutaneous thermal and mechanical 
sensitivity. CGRP-containing nerves are peptidergic and generally responsive to thermal stimuli 
(Jankowski and Koerber, 2010). Therefore, we expected to find a loss of CGRP-ir nerves to be 
accompanied by abnormal thermal sensitivity. However, CGRP-ir IENF loss was associated 
with increased mechanical sensitivity in 1 month old LC-depleted mice. Mice could be 
hypersensitive to mechanical stimuli because the remaining IENFs (non-peptidergic) become 
hypersensitive due to an imbalance between peptidergic and non-peptidergic IENFs. 
Keratinocytes can influence cutaneous sensitivity (Schmelz, 2011) and LCs communicate with 
keratinocytes through cytokine signaling (McKenzie and Sauder, 1990b; Matsue et al., 1992; 
Parkinson et al., 1993). Therefore, a lack of interaction between LCs and keratinocytes may 
cause keratinocytes to alter sensitivity. Nevertheless, our data show LCs provide trophic support 
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for CGRP-producing nerves that are required for mechanical sensitivity. Further, these data 
support previous studies that found allodynia to be associated with cutaneous 
neurodegeneration (Sommer and Schafers, 1998; Renn et al., 2011a; Renn et al., 2011b; Ward 
et al., 2011). 
We determined that LCs are necessary for maintaining epidermal innervation, but by 
what mechanism do LCs provide support? Neurodegeneration is often associated with a 
reduction in neurotrophic factors (Anand et al., 1991; Pittenger and Vinik, 2003). Since 
neurotrophic factors such as NGF and GDNF support CGRP-ir and non-peptidergic nerves 
(Lindsay, 1996; Montano et al., 2010), we examined if IENF loss was associated with a 
reduction in NGF and GDNF. BDNF influences large fiber mechanoreceptors. A reduction in 
BDNF may result in altered mechanical sensitivity. Therefore, BDNF was also measured. LC 
depletion in 1 month old mice was accompanied by a 75% and 95% reduction in NGF and 
GDNF, respectively. This implies that LCs regulate a substantial amount of NGF and GDNF 
expression in the epidermis. BDNF was unaltered suggesting that large fiber mechanoreceptors 
may not be altered. Due to the fact that epidermal cells, mostly keratinocytes, produce NTFs we 
needed to confirm that NTF reduction after LC depletion was not cause by a reduction in 
epidermal content. LC depletion did not alter epidermal content implying that LCs provide 
trophic support for CGRP- containing nerve fibers by modulating NGF and GDNF gene 
expression in 1 month old mice.    
There are two potential mechanisms for how NGF and GDNF levels changed. First, NGF 
mRNA has been identified in a LC-like cell line (Torii et al., 1997). If LCs produce NTFs in vivo, 
a reduction in LCs would cause a decrease NTF expression. Second, the epidermis is primarily 
composed of keratinocytes, which secrete NTFs, and LCs and keratinocytes communicate with 
each other. It is possible that a lack of interaction between LCs and nearby keratinocytes results 
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in decreased NTF expression which leads to IENF reduction. Clearly, future studies are required 
to determine how LCs alter NTF expression in 1 month old mice.  
LCs and IENFs are reduced with aging suggesting the relationship between LCs and 
IENFs may be different with age. Aging reduced LCs and PGP9.5-ir IENFs. Small but non-
significant reductions in CGRP-ir and non-peptidergic IENFs were observed with age indicating 
PGP9.5-ir IENFs reduction is due to both subtypes being affected. Earlier, we established that 
LCs are essential for maintaining IENFs. It is likely that the reduction in IENFs in older mice was 
due to a reduction in LCs. Since age did influence LCs and IENFs, we investigated whether 
IENF loss after LC depletion was altered in older mice. However, first it was necessary to 
determine if DT influenced IENFs in older mice. PGP9.5-ir IENFs were reduced in 10 month old 
C57BL/6 mice. To assess if this reduction is due to DT affecting LCs, we examined LCs in 10 
month old C57BL/6 mice. DT did not alter LCs in older C57BL/6 mice suggesting the reduction 
in IENFs is not a response to changes in LCs but to DT administration. Although it remains 
unclear how DT reduced IENFs and why it only occurred in older mice, a potential mechanism 
could be through CD9, which is expressed in the peripheral nervous system of mice (Schmidt et 
al., 1996) and known to promote DT/DTR binding (Nakamura et al., 1996). These data imply 
that age influences LCs and IENFs whereas DT only alters IENFs. Moreover, analysis of 
epidermal thickness reveal changes in LCs and IENFs with age and DT is not due to reduced 
epidermal content.   
We revealed age and DT are factors when assessing IENFs and LCs status. While 
taking these factors into consideration, IENF density was analyzed in older LC-depleted mice. 
When compared to 1 month old LC-depleted mice, PGP9.5-ir IENFs were further reduced. This 
was also significantly lower than the reduction found in C57BL/6 mice suggesting LC depletion 
caused IENF degeneration. There are multiple explanations for why a greater effect was 
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observed in older mice. First, DT reduces innervation in older mice. As a result, a greater 
decrease may be a combined effect of LC depletion and DT. Second, LCs were reduced in 
older vehicle-treated mice. Therefore, a greater decrease may be due to the fact that there was 
less trophic support by LCs to begin with and when removed this caused an even greater 
reduction.  In any case, differences in innervation are not due to changes in epidermal content 
which was reflected in epidermal thickness. Quantitative analysis of IENF subtypes revealed 
peptidergic IENFs were not altered while the epidermis was almost completely absent of non-
peptidergic IENFs. This suggests LCs provide trophic support for non-peptidergic IENFs in older 
mice. Due to a limitation of resources, we were unable to assess sensitivity in older mice. Since 
non-peptidergic IENF loss has been associated with increased sensitivity to noxious stimuli 
(Golden et al., 2010), it is possible that LC depleted mice may be more sensitive to noxious 
stimuli.  
With age the IENF subtype supported by LCs switched from CGRP-producing IENFs to 
non-peptidergic IENFs suggesting the mechanism used to support IENFs may have changed. 
Therefore, NTF gene expression was examined. Despite the dramatic decrease in IENF density 
in older mice, BDNF, NGF, and GDNF levels were not altered by LC depletion. It is possible that 
NTF levels did not change because LC’s influence on NTF expression is stronger in younger 
mice. Also, LCs could provide trophic support through other neurotrophic factors or cytokine 
signaling such as interleukin-1β (IL-1β). Since LCs produce IL-1β (Matsue et al., 1992) and IL-
1β increases neurite outgrowth in culture (Edoff and Jerregard, 2002), LCs may be directly 
affecting IENFs through IL-1β. Altogether, data from older mice suggest LCs use a different 
pathway to provide trophic support for non-peptidergic IENFs which requires further 
investigation.   
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Collectively, we reveal that LCs play a pivotal role in maintaining epidermal innervation. 
Yet, age-dependent changes in NTF expression indicate the process by which LCs provide 
support involves multiple pathways. Despite this conundrum, our study provides evidence that 
the relationship between LCs and epidermal nerve fibers is a two-way street and that future 
studies are needed to determine how LCs help maintain IENFs in older mice. This data adds 
another level to the already complex nerve-immune cell relationship within the skin. With 
respect to peripheral neuropathy, it remains unclear what steps occur prior to neuropathy. 
However, data from this study suggest that LC reduction results in IENF loss and 
hypersensitivity which may mean peripheral neuropathy and cutaneous hypersensitivity 
associated with diseases may be induced or exacerbated by a loss of LCs. This data can also 
be useful in understanding nerve regeneration during wound healing. Since LCs are necessary 
for maintaining IENFs, LCs may need to be present to obtain full nerve regeneration. Altogether, 
our data provides evidence of a new role for LCs.   
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Tables 
Table 1 Epidermal Thickness in C57BL/6 and Lang-DTR Mouse Footpad 
 
C57BL/6 Lang-DTR 
1 Month   
Vehicle 58.14 ± 4.92 59.91 ± 6.82 
 
DT 
 
50.82 ± 4.51 51.99 ± 2.19 
   
10 Month   
Vehicle 64.11 ± 3.14 67.89 ± 2.45 
 
DT 
 
66.28 ± 4.39 66.55 ± 3.33 
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Table 1 Epidermal thickness in C57BL/6 and Lang-DTR mice 
Epidermal thickness was measured in footpad sections from C57BL/6 and Lang-DTR mice 
treated with vehicle or DT at 1 and 10 months of age. Data is expressed as Mean ± SEM. 
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Figures 
 
Figure 1 
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Figure 1 LC status in C57BL/6 mice 
Footpad sections from C57BL/6 mice at 1(a and b) and 10 (c and d) months of age were stained 
for langerin (a-d) after treatment with vehicle (a and c) or DT (b and d). Images were taken with 
a 60x objective. Bar graphs represent LC density (e), LC Size (f), and the % of epidermal area 
occupied by LCs (g). Scale bar = 20µm. Data is expressed as Mean ± SEM. 
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 Figure 2 
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Figure 2 PGP9.5-ir, peptidergic, and non-peptidergic IENFs in C57BL/6 mice 
Footpad sections from 1 and 10 month old (a-d and e-h, respectively) vehicle- (a, c, e, and g) or 
DT-treated (b, d, f, and h) C57BL/6 mice were stained for PGP9.5 (a, b, e, and f) and CGRP (c, 
d, g, and h) to reveal total IENFs and IENFs within the peptidergic subtype, respectively. Images 
were taken with a 60x objective. Scale bar represents 20µm. Bar graphs represent PGP9.5-ir (i), 
CGRP-ir (j), and CGRP(-)-ir (non-peptidergic, k) IENF density. *p=0.007 when PGP9.5-ir IENF 
density is compared between aged vehicle- and DT-treated mice. Data is expressed as Mean ± 
SEM. 
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Figure 3 
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Figure 3 LC depletion in Lang-DTR mice 
Images of footpad sections from vehicle- (a-c) and DT-treated (d-f) Lang-DTR mice 
immunostained for langerin were taken with a 40x objective. Transmitted light images reveal the 
morphology of the epidermis in vehicle- (b) and DT-treated (e) mice. Scale bars in c and e 
represent 20µm. Data are represented as Mean ± SEM. 
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Figure 4 
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Figure 4 Epidermal innervation in 1 month old Lang-DTR mice 
Images of PGP9.5-ir (a and b) and CGRP-ir (c and d) IENFs in the footpad of 1 month old 
vehicle- (a and c) and DT-treated (b and d) Lang-DTR mice were taken with a 60x objective. 
Scale bar represents 20µm. Bar graph represents PGP9.5-ir, CGRP-ir, and CGRP(-)-ir IENF 
density in 1 month old Lang-DTR mice. *p=0.036 when PGP9.5-ir IENF density for vehicle- and 
DT-treated mice are compared. **p=0.045 when CGRP-ir IENF densities are compared 
between vehicle- and DT-treated mice. Data is represented as Mean ± SEM. 
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Figure 5 
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Figure 5 LCs in 1 and 10 month old Lang-DTR mice 
Images reveal langerin immunoreactivity in footpad sections of 1 and 10 month old Lang-DTR 
mice (a and b, respectively). Scale bar represents 20µm. 
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Figure 6 
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Figure 6 Epidermal innervation in older Lang-DTR mice 
(a) and (b) reflects PGP9.5-ir IENFs in vehicle- and DT-treated 10 month old Lang-DTR mice, 
respectively. (c) and (d) show CGRP immunoreactivity in footpad sections of vehicle- and DT-
treated 10 month old Lang-DTR mice, respectively. All images were taken with a 60x objective. 
Scale bar represent 20µm. Bar graph represents PGP9.5-ir, CGRP-ir, and CGRP(-)-ir IENF 
density in 10 month old Lang-DTR mice. *p<0.001 when older vehicle- and DT-treated mice are 
compared. **p=0.007 when older vehicle- and DT-treated mice are compared. Data is 
represented as Mean ± SEM. 
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Figure 7 
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Figure 7 Neurotrophic factor expression in epidermal sheets of Lang-DTR mice 
Bar graphs represent fold changes in BDNF (a), NGF (b), and GDNF (c) relative to controls. 
Gene expression was made in both 1 and 10 month old mice. *p=0.012 when vehicle- and DT-
treated mice are compared at 1 month of age. **p=0.015 when 1 month old vehicle-and DT-
treated mice are compared. Data is expressed as Mean ± SEM. 
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Figure 8 
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Figure 8 Mechanical sensitivity in 1 month old Lang-DTR mice 
Line graph (a) represents mechanical sensitivity. Measurements were taken one day prior to DT 
treatment (B) and one (day1) and thirteen (day13) days after the first injection. Filled and open 
and circles represent vehicle- and DT-treated C57BL/6 mice, respectively. Filled and open 
squares represent vehicle- and DT-treated Lang-DTR mice. *p<0.001 when DT-treated Lang-
DTR mice on day13 are compared to their baseline. **p<0.001 when DT-treated Lang-DTR 
mice are compared to vehicle-treated Lang-DTR on day13. Data is expressed as Mean ± SEM. 
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Abstract 
Cutaneous infections are a leading cause of hospitalization in diabetic patients. Langerhans 
cells (LCs) are antigen-presenting cutaneous dendritic cells that protect against infections, but 
the effect of diabetes and aging on these cells is unclear. We examined LCs in footpads of rats 
with streptozotocin-induced diabetes at 3 months of age following 4 weeks of diabetes, and at 6 
months following 16 weeks of diabetes. Immunostaining of LCs using the selective marker 
protein langerin showed LC surveillance increased between 3 and 6 months of age as a result 
of increased LC numbers and size in control rats.  In diabetic rats, LC numbers increased with 
age but, unlike 6 month old controls, cell size did not, suggesting that diabetes impairs the 
increase in cell size that is a hallmark of LC maturation.  Immunostaining also revealed that 
diabetes reduced LC numbers after 4 weeks and numbers and sizes following 16 weeks. We 
examined the relation between LC and innervation and found that, while axon density 
decreased with aging, it was not affected by diabetes. However, LCs expressing the neuronal 
marker PGP9.5 represented a source of error in axonal counts.  These findings support the 
hypothesis that diabetes substantially impacts LC proliferation and maturation independent of 
effects on cutaneous innervation.  Accordingly, the interactions of diabetes and aging on LCs 
may be important factors in predisposing diabetic patients to cutaneous ulcers and infections. 
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Introduction 
Infection of cutaneous ulcers is a major cause for hospitalization and amputation among 
the diabetic population (Reiber et al., 1998; Cruciani et al., 2009; Xie et al., 2010). Although the 
incidence of cutaneous infections is not greater (Oumeish, 2008), healing time is delayed and 
morbidity more severe (Ferringer and Miller, 2002; Xie et al., 2010).   The reasons for the 
greater frequency of ulcer pathologies in diabetes is unclear, but accompanying neuropathies 
and angiopathies may well contribute to delayed healing (Meijer et al., 2001; Wohlrab et al., 
2007; Ghanassia et al., 2008; Lauterbach et al., 2010).  In addition, the skin contains an intrinsic 
immune system that helps protect against infection. Antigen presenting cells (APCs) which 
include macrophages, B cells, and dendritic cells, and are critical for preventing foreign antigen 
infiltration. Impairments in the cutaneous immune system could possibly contribute to the poor 
outcome in diabetics developing cutaneous ulcers. 
The main APC in the epidermis is the Langerhans cell (LC). LCs are stellate dendritic 
cells derived from hematopoietic precursors (Merad et al., 2002), and are also found within 
stratified squamous epithelium  in other body regions (Pieri et al., 2001; Merad et al., 2008) 
including the oral cavity (Rowden, 1981), esophagus (Rowden, 1967), and vagina (Iijima et al., 
2007). LCs express antigen-presenting proteins such as major histocompatibility complex 
(MHC)- I and II, human leukocyte antigen-DR (HLA-DR), and CD1a (Harrist et al., 1983; Ayala-
Garcia et al., 2005; Mutyambizi et al., 2009; Romani et al., 2010), and their primary function is 
believed to be to present atypical self or foreign antigens to T cells (Merad et al., 2008; Zaba et 
al., 2009).  LCs are also characterized by the presence of the type II Ca2+-dependent lectin, 
langerin (Valladeau et al., 1999; Valladeau et al., 2000; Romani et al., 2010). Langerin has a 
carbohydrate recognition domain that specifically binds to and is involved in uptake of mannose-
expressing antigens (Valladeau et al., 2000; Chatwell et al., 2008). The primary function of 
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langerin is thought to be ligand internalization associated with Birbeck granule formation, a 
feature exclusive to epidermal LCs (Valladeau et al., 1999; Valladeau et al., 2000; 
Kissenpfennig et al., 2005).  Consequently, these cells are important in cutaneous immune 
responses (Mutyambizi et al., 2009; Romani et al., 2010).  
Diabetes could influence LCs through direct effects on cell maturation or longevity, or 
indirectly through microvascular changes (Jeffcoate and Harding, 2003; Wohlrab et al., 2007) or 
altered keratinocyte growth factor production.  Further, intraepidermal nerve fibers (IENFs) 
appear to regulate LC composition, as peripheral degeneration increases LC numbers (Hsieh et 
al., 1996; Stankovic et al., 1999; Lindenlaub and Sommer, 2002; Lauria et al., 2005b; Siau et 
al., 2006; Jin et al., 2008). Since neuropathic changes are common in diabetes (Lauria et al., 
2005b; Lauria and Lombardi, 2007; Beiswenger et al., 2008; Sommer, 2008; Nebuchennykh et 
al., 2009), it is important  to assess whether  changes in IENFs may be a factor mediating 
diabetes’ effect on LCs. 
Thus far, two studies have quantified the effect of diabetes on LCs, yielding conflicting 
results (Ziegler and Standl, 1988; Lauria et al., 2005b). These studies examined skin from 
different locations, species, and at different times after the onset of diabetes using either MHC-II 
or protein gene product 9.5 (PGP9.5) as a LC marker.  PGP9.5 is expressed by LCs  (Hsieh et 
al., 1996; Stankovic et al., 1999; Lin et al., 2001; Lauria et al., 2005b; Beiswenger et al., 2008; 
Jin et al., 2008), but is also present within IENFs and commonly used to quantify innervation 
(Jackson and Thompson, 1981; Lauria et al., 2005b; Lauria and Lombardi, 2007; Beiswenger et 
al., 2008; Sommer, 2008; Lauria et al., 2009; Nebuchennykh et al., 2009). Since LCs form 
intimate associations with IENFs, questions have emerged regarding whether PGP9.5-
immunoreactive (ir) LCs may be a confounding factor in quantifying IENFs.  
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The purpose of this study was to systematically examine the effect of different durations 
of streptozotocin-induced diabetes and, concurrently, the effects of age on epidermal LCs and 
innervation using dual staining for PGP9.5 and langerin.  Our objective was to identify cellular 
mechanisms that could contribute to the more profound incidence and severity of cutaneous 
infections and cutaneous ulcerations in diabetic patients.  
 
Material and Methods 
All animal protocols were approved by the University of Kansas Medical Center’s 
Animals Care and Use Committee, and were in accordance with the National Institute of Health 
guidelines for the care and use of laboratory animals. 
Sixty-day old female Sprague Dawley rats (Harlan Laboratories, Inc., Indianapolis, IN) 
were anesthetized (60mg/kg ketamine HCL, Ketaject, 0.4 mg/kg atropine sulfate, and 8 mg/kg 
xylazine Xyla-Ject, intraperitoneal (i.p.) injection) and bilaterally ovariectomized under aseptic 
conditions (Blacklock and Smith, 2004). Estrogen is known to alter LC numbers (Koyama et al., 
1987; Hernandez-Segura et al., 2005; Kovats and Carreras, 2008), and reproductive hormone 
levels vary with age and reproductive status in both males in females. Therefore, using females 
with constant and very low levels of estrogen after ovariectomy (Strom et al., 2008) eliminates a 
significant confounding variable. 
Diabetes Induction  
One week following ovariectomy, blood samples were taken from the tail vein and blood 
glucose was measured with a TrueTrack Smart System glucometer (Ft Lauderdale, FL). 
Animals then received a single i.p. injection of streptozotocin (STZ, 60mg/kg, in 10mM citrate 
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buffer with 0.9%NaCl, pH4.5, (n=17) or vehicle buffer (n=11). Three days following STZ 
administration, blood glucose levels were again assessed, and animals with levels ≥270mg/dl 
were considered diabetic and included in the experiment. Animals were maintained for 4 (n=6) 
or 16 weeks (n=11) at which time, blood glucose and weight were measured. 
Immunostaining 
Animals were anesthetized with Beuthanasia (195mg/kg Sodium Pentobarbital, 25mg/kg 
Phenytoin Sodium, i.p.;Schering-Plough Animal Health Corp., Union, NJ) and footpads were 
harvested. Tissue was immediately immersed in Zamboni's fixative for 24-hours. Tissue was 
rinsed daily in 0.1M phosphate buffered saline (PBS) for 10-14 days. After rinsing, footpads 
were immersed in 30% sucrose solution. Tissue was frozen in tissue freezing medium (Electron 
Microscopy Sciences, Hatfield, PA) and stored at -80˚C. Footpads were serially sectioned at 18 
µm thickness perpendicular to the surface and along the length of the footpad. Three sections 
spaced 342μm were analyzed per animal.  
Sections were stained with goat anti-langerin antiserum (1:100, Santa Cruz 
Biotechnology, Santa Cruz, CA,) to identify epidermal LCs. Immunofluorescence with the 
langerin antibody in tissue from mice expressing enhanced green fluorescent protein under the 
control of the langerin gene (kindly provided by Dr. Bernard Malissen) confirmed that our 
langerin antibody was specific for Langerhans cells. Also, sections were stained with a rabbit 
anti-human PGP9.5 antibody (1:600, AbD Serotec, Oxford, UK,) to identify cutaneous nerve 
fibers. Western blots of dorsal root ganglion protein immunostained with PGP9.5 antibody 
showed a band of 27kDa, serving as a positive control (Doran et al., 1983). Sections were 
blocked with donkey serum followed by overnight incubation with primary antibodies, rinsing in 
PBS with 3% triton for 30 minutes, and incubation for one hour with secondary antibodies (Cy3 
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Donkey anti-Goat and Alexa 488 Donkey anti-Rabbit; Jackson ImmunoResearch Laboratories, 
Inc. West Grove, PA). Sections were rinsed in PBS with 3% triton and mounted with 
Fluoromount G.  
Confocal Imaging 
Images were taken with 60X or 100X oil immersion objectives on an Eclipse 90i 
microscope equipped with a Nikon C1si confocal system and a D-Eclipse camera (Melville, NY). 
2-D images were created using maximum projection on volume renderings of Z-stacks. To 
create 3-dimensional (3-D) images, image acquisition and volume rendering of Z-stacks were 
performed using Nikon NIS-elements Advance Research 3.10 software (Melville, NY).  
Stereological Analysis of LCs  
For each animal, three sample fields (0.148mm2/field) per section were obtained with a 
20X objective using a Photometrics Cool SNAP-EZ Camera (Roper Scientific Inc., Tucson, AZ) 
and Nikon Eclipse TE300 inverted microscope, and analyzed (MetaMorph, Molecular Devices, 
Downingtown, PA). Epidermal area within the sample field was estimated by tracing around the 
stratum granulosum and basal cell layers while excluding the stratum corneum. Numbers of 
cells -positive for langerin immunoreactivity (+) were counted.  The contribution of langerin+ 
cells to the overall epidermal sample area was obtained by superimposing a stereological grid 
(13.23µm intersections), counting numbers of intersects overlying LCs, and multiplying by the 
grid square area corresponding to each intersection (175µm2), using approaches similar to 
previous studies (Zoubina et al., 1998; Blacklock et al., 2004; Blacklock and Smith, 2004). The 
apparent percentage of epidermal area occupied by langerin+ cells was also calculated by 
dividing total langerin area by epidermal area and then multiplying by 100. To obtain an index of 
overall LC size, total langerin+ area was divided by the number of langerin+ cells. 
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Quantitation of IENFs 
  A method originally defined by Kennedy et al. (Kennedy et al., 2005) and adopted by 
European Federation of Neurological Societies (EFNS) (Lauria et al., 2005a) was used to 
quantify epithelial innervation. Individual IENFs immunostained for PGP9.5 that cross the 
dermal-epidermal junction were counted while excluding any secondary branching. Counts were 
divided by the length of the epidermis and expressed as IENF/mm. Individual IENFs were 
visually counted at three regions along the length (distal, middle, and proximal) of each footpad 
section with a 40X objective and 10X eyepiece on a Nikon Eclipse TE300 inverted microscope 
(Nikon Corp., Tokyo, Japan). Each region spanned 0.42mm. To determine epidermal length, the 
basement membrane was measured. For each region, IENF counts were divided by epidermal 
length to obtain PGP9.5+ IENF/mm.  We also repeated these counts in samples double stained 
for langerin, in which PGP9.5+ projections co-labeled with langerin were excluded from counts. 
These data are expressed as PGP9.5+/langerin- IENF/mm.   
Statistical Analysis 
Weight and blood glucose levels were analyzed with two way repeated measures 
analysis of variance and Student-Newman-Keuls post-hoc analysis. Differences in epidermal LC 
density, size, and percent epidermal area were compared by t-test or two way analysis of 
variance and Student-Newman-Keuls post-hoc analysis. IENF/mm data were compared by t-
test with Bonferroni correction. The effect of age on nerve density was analyzed with two way 
analysis of variance. Differences were considered significant if p value was <0.05. Data are 
expressed as Mean ± Standard Error Mean (SEM).  
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Results 
Blood glucose and body weight  
 To confirm diabetic status at 4 and 16 weeks following STZ injections, blood glucose 
levels were measured (Table 1). Vehicle-injected rats remained in the euglycemic range, while 
glucose levels of STZ-treated rats at 4 and 16 weeks were significantly greater than their aged-
matched controls (p<0.001 and p<0.001, respectively). Moreover, glucose levels for STZ-
treated rats at 16 weeks were higher than levels at 4 weeks post-STZ (p<0.001). Age did not 
affect body weight within vehicle- and STZ-treated groups (Table 1). However, body weight was 
significantly reduced after 4 and 16 weeks of diabetes (p<0.001 and p<0.001). 
Langerin immunostaining in euglycemic rats at 3 months of age 
  Immunostained footpad sections of 3-month-old rat 4 weeks following vehicle injection 
revealed a langerin+ epidermal cell population. Langerin+ cells were primarily found within the 
stratum spinosum, granulosum and basal layers (Fig. 1a), but seen occasionally in the stratum 
corneum and below the basement membrane (not shown).  Langerin+ cells were stellate or 
spindle-shaped with extensive processes, sometimes stretching across all epidermal layers 
except the stratum corneum. Langerin+ appeared to be intra-cytoplasmic and punctuate, 
localizing mainly to the soma with less accumulation in distal-most processes (Fig. 1a, See 
Electronic Supplementary Movie 1, S1).  
Langerin immunostaining in euglycemic rats at 6 months of age  
LCs appeared to be increased in non-diabetic rats at 6 months relative to 3 months (Fig. 
1b). Quantitative analysis showed a 75% increase in LC density in non-diabetic animals when 
compared to 3 month old non-diabetic animals, (p<0.001, Fig. 1e). Moreover, at 6 months of 
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age, LCs had longer processes and slightly larger somas when compared to three month old 
animals (Fig. 1b). LC size was 38% greater at 6 months as compared to rats at 3 month of age 
(p<0.001, Fig.1f). Overall, the percentage of epidermal area occupied by LCs increased by 
141% between 3 and 6 months of age (p<0.001, Fig. 1g). 
Langerin immunostaining in hyperglycemic rats at 3 months of age 
Rats at 3 months of age that received a single i.p. injection of STZ 4 weeks earlier 
appeared to have fewer LCs when compared to 3 month old euglycemic rats (Fig. 1c), and 
quantitative analysis confirmed a 17% decrease (p=0.032, Fig. 1e).  However, 4 weeks of 
diabetes did not alter either the average size of LCs (Fig. 1f) or the percentage of epidermal 
area occupied by LCs (Fig. 1g). 
Langerin immunostaining in hyperglycemic rats at 6 months of age 
 Rats aged 6 months rendered diabetic for 16 weeks displayed numerous small LCs in 
their epidermis (Fig. 1d). Relative to younger diabetic rats, there was a 76% increase in LCs in 
6-month-old diabetic rats (p<0.001, Fig. 1e). However, the magnitude of the age-related 
increase that occurred in non-diabetic rats was attenuated by diabetes (p=0.041, Fig. 1e). In 
addition, LC size showed no age-related increase between 3 and 6 months in diabetic animals 
(Fig. 1f).  When compared to aged controls, LC sized decreased by 37% after 16 weeks of 
diabetes (p<0.001, Fig. 1f). The overall percentage of epidermal area occupied by LCs 
increased by 61% between 3 and 6 months, but remained markedly lower than that of 
euglycemic rats at 6 months (p<0.001, Fig. 1g). 
PGP 9.5 immunostaining of Langerhans cells after 4 weeks of diabetes    
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Footpad sections from three-month-old non-diabetic and diabetic rats one month after 
inducing diabetes showed PGP9.5+ within the cytoplasm of stellate and spindle-shaped cells 
within non-keratinized epidermis (Fig. 2a and b, Electronic Supplementary Movie, S2). These 
cells frequently displayed long processes oriented perpendicularly to the epidermal longitudinal 
axis (Fig. 2a, Electronic Supplementary Movie, S2).   
Co-stained sections were examined to define the contributions of LCs to PGP9.5+ 
structures. Langerin revealed populations of epidermal cells as described above (Fig. 2c and d). 
Double-staining showed co-localization of langerin in PGP9.5+ stellate-shaped cells (Fig. 2e 
and f, Electronic Supplementary Movie, S2).  PGP9.5 expression was uniform within the cell 
body but was often patchy within LC processes. In addition, PGP9.5 was occasionally located 
only on profiles that appeared to contact langerin+ LC somata. All cells with PGP9.5+ also 
contained langerin+.  However, some langerin+ LCs within the epidermis (Fig. 2e and f) and 
occasionally within the immediate sub-epidermal layer (not shown) lacked PGP9.5+. The 
expression patterns of langerin and PGP9.5 in LCs did not appear to be altered as a result of 4 
weeks of diabetes (Fig. 2.a-f). 
PGP 9.5 immunostaining of Langerhans cells after 16 weeks of diabetes  
Epidermal sections of 6-month old rats that received streptozotocin or vehicle injection 4 
months earlier showed langerin and PGP9.5 immunostaining similar to that of rats at 3 months 
of age.  Co-localization of PGP9.5 and langerin within LCs also appeared comparable and did 
not appear to be affected by diabetes (Fig. 3a-f).  The increased langerin+ LC numbers 
associated with aging was accompanied by a proportionate increase in numbers of PGP9.5+ 
cells in euglycemic and hyperglycemic rats.  Similarly, the increased size of LCs in the non-
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diabetic rats appeared to be accompanied by proportionate increases in PGP9.5 
immunoreactivity, so that there were no obvious changes in LC phenotype. 
Intraepidermal nerve fibers  
Footpad sections double-stained for PGP9.5 and langerin were examined to determine 
how age and diabetes affect IENFs and their relationship to LCs. PGP9.5 immunostaining 
revealed large nerve bundles running parallel to the basement membrane. Smaller branches 
emanated from the bundles and penetrated the epidermis perpendicularly (Fig. 2a and b). 
To examine the spatial arrangement of PGP9.5+ axons and langerin+ LCs, 3-D 
reconstruction of confocal images from double-stained footpad sections was performed 
(Electronic Supplementary Movie, S2). Confocal images revealed PGP9.5+ fibers that could be 
traced to subepidermal nerve bundles frequently showed intimate associations with langerin+ 
LCs; nerve fibers were also frequently intermingled between the fine processes of the LCs 
(Figs. 2 e and f, 3e and f, Electronic Supplementary Movie, S2). In fact, in PGP9.5 
immunostained specimens, it was often impossible to distinguish with certainty which ‘fibers’ 
were axons and which were LC projections. 
To determine whether LC projections contribute to counting errors that may occur when 
quantifying epidermal innervation, we performed IENF counts using images immunostained for 
PGP9.5 and langerin. Sections co-stained for langerin revealed LC extensions could be 
discerned more readily.  PGP9.5+ LC processes contributed 15-19% of overall IENF counts for 
non-diabetic rats at both 3 (Fig. 2g) and 6 months of age (Fig. 3g), but achieving statistical 
significance only at 3 months (p=0.024, Fig. 2g). LC contributions to counts in diabetic groups 
were more modest and not statistically significant (Fig. 2g and 3g). 
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 In non-diabetic rats we detected a decrease in numbers of both corrected (i.e., LC 
processes excluded, p=0.005) and uncorrected (p<0.001) IENF counts between 3 and 6 months 
of age (Fig. 2g and 3g). There were no differences in corrected and uncorrected IENF counts 
between 3 and 6 month old diabetic rats. Irrespective of whether IENF counts were corrected for 
LC contributions, there was no significant difference between diabetic and non-diabetic rats at 4 
and 16 weeks after induction (Figs. 2g and 3g).    
 
Discussion  
Cutaneous infections are the primary cause of lower limb amputation among diabetic 
patients. Understanding the effect of diabetes on APCs, a primary defense mechanism against 
external pathogen invasion, is therefore critical. While a number of proteins have been used to 
identify LCs, langerin is perhaps the most selective marker, at least in mice and humans 
(Valladeau et al., 1999; Stoitzner et al., 2003).  Although rats are frequently used in research on 
diabetes, aging and neuro-immune interactions, to date descriptions of langerin expression in 
the rat are limited (Meyer et al., 2010). Concordant with reports in other species, our 
immunostaining studies show langerin+ is present throughout the soma and processes of all 
identified LCs, confirming langerin is a useful LC marker in rat.  
 An effect of aging on immune status and immune cell function is not unexpected given 
an animal’s cumulative exposure to antigens in the environment.  Accordingly, we found that LC 
density increased between 3 and 6 months in non-diabetic rats, implying greater LC proliferation 
(i.e. more cell migration or replication) in older rats. LC size also appeared to increase with age.  
Previous studies proposed that LC size is an indicator of functional maturity in LCs (Larsen et 
al., 1990; Nishibu et al., 2006).  Our findings therefore suggest that the proportion of functionally 
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mature LCs is greater in the older rats. Collectively, the increase in LC size and numbers 
resulted in an overall increase in the relative contribution of these cells to the foot pad skin, 
implying that LCs may be able to survey a greater volume of foot epidermis in older animals.  
Age-related changes in epidermal LC composition may vary as a function of species and 
location.  The rat foot pad represents the main point of physical contact with the external 
environment and therefore is constantly exposed to potential antigens.  In contrast, studies in 
mice and humans suggest that other sites may not undergo similar increases; for example, skin 
samples from ear and buttocks showed evidence of decreased LC composition with age 
(Bhushan et al., 2002; Cumberbatch et al., 2002; Agrawal et al., 2007). Varied  findings may be 
due to differences in species (Breathnach, 1991), skin type (e.g., glabrous vs. hairy), location 
(Berman et al., 1983; Thomas et al., 1984), and differences in age-related LC changes may not 
be surprising.  Nonetheless, the foot is of particular clinical importance because it is frequently 
affected by cutaneous ulceration and infection in diabetic patients, often resulting in amputation.  
Hence an understanding of changes in LCs in the hind paw is of particular clinical relevance.  
Relative to control subjects, rats with STZ-induced diabetes had reduced hind paw LC 
density at 4 weeks post-treatment. However, neither LC size nor the percentage of epidermal 
area occupied by LCs was statistically different from control values. These results suggest that 
in the early stages, diabetes selectively reduces LC numbers, presumably by reducing the 
proliferation of these cells. Despite this reduction, the overall contribution of LCs to foot pad 
cutaneous composition remained relatively normal.  Although functional studies are necessary 
to determine whether a normal immune response is retained, these findings imply that area of 
cutaneous tissue surveyed by LCs remains relatively normal in early STZ-induced diabetes. 
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In contrast, rats that endured 16 weeks of hyperglycemia showed decreases in LC 
density, size and the percentage of epidermal area occupied by LCs. This suggests that a 
longer duration of hyperglycemia may impair both proliferation and maturation.  These findings 
are in agreement with those of Zeigler and Standl who found a reduction in LCs in early Type I 
diabetes in humans (Ziegler and Standl, 1988), but differ from a report of increased LCs in the 
STZ diabetic rat (Lauria et al., 2005b).  As noted above, differences may reflect regional 
variations, but may also represent differences in quantitative methods (correcting for length only 
vs. epidermal volume), and in LC markers (langerin vs. PGP9.5, which does not label all LCs).  
In any event, our study shows diabetes can have a negative effect on LC proliferation and 
maturation, leading to reduced epidermal antigen surveillance. 
As in euglycemic rats, the percentage of epidermal area occupied by LCs in diabetic rats 
at 6 months of age was increased relative to that at 3 months, although the increase was 
attenuated in diabetic animals. This was due to combined effects on LC proliferation and 
maturation, as diabetes diminished both cell density and size. Thus, duration of diabetes 
appears to affect LC dynamics negatively. It is unclear whether age of onset is also a factor. In 
any event, the effects of diabetes were certainly more pronounced in aged rats.   
Because previous reports have suggested that changes in epidermal innervation can 
alter LC density, it was important to determine if innervation was affected in our STZ-diabetic 
rats. However, because LCs express PGP 9.5 and are often intimately associated with axons, 
we were concerned that fine PGP 9.5+ processes from LCs could contribute to IENF counts.  
We therefore used dual immunostaining to more fully investigate the relationship between axons 
and LCs.  Most LCs expressed both langerin and PGP 9.5, but a significant proportion of LCs 
expressed langerin but not PGP 9.5, with the incidence of these cells increasing towards the 
apical portion of the dermal papillary layer. Variation in PGP+ has been reported previously, but 
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only in association with phenotypic changes occurring with loss of cutaneous innervation (Hsieh 
et al., 1996). These findings indicate that while a number of LCs do not express PGP 9.5, most 
LCs do express this neuroendocrine marker. 
 ‘Axon’ counts in material double-stained for langerin revealed that PGP 9.5+ LC 
processes may be a potential source of error. While this occurred in all specimens, the 
contribution was greatest within non-diabetic animals. We attribute this to the findings that 
diabetes reduces the number, size and complexity of LCs.  These results show that PGP9.5+ 
within LC processes can be a source of error in IENF counts if they are not excluded by co-
staining with a more selective LC marker such as langerin.   
 When we compared IENF density between 3 and 6 months in non-diabetic rats, we 
found a significant decrease in IENFs when counts were either corrected or not corrected for 
contributions PGP 9.5+ LC processes.  These findings agree with those of others who also 
report a decrease in innervation with age (Goransson et al., 2004; Lauria et al., 2010). It 
appears that cutaneous density decreases in rats as a function of age. 
In contrast, there was no clear age-related decline in IENF density in diabetic rats.   At 4 
weeks post-treatment, axon numbers did not differ significantly from controls irrespective of 
whether or not we corrected for LC contribution.  This is in accord with a prior report failing to 
detect axon reductions after 4 weeks of diabetes (Karanth et al., 1990). Similarly, IENF counts 
at 16 weeks post-treatment were not significantly different from those at 4 weeks. This finding 
was somewhat unexpected as several other studies have reported reduced numbers of 
cutaneous fibers in rats at 12 weeks or later post-STZ (Lauria et al., 2005b; Toth et al., 2006; 
Leonelli et al., 2007; Roglio et al., 2007; Jin et al., 2009). Because our rats showed all the 
classical signs of insulin-deficient diabetes including hyperglycemia, weight loss, polydipsia and 
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polyuria, the difference is unlikely to be attributable to ineffective STZ treatment. Other factors 
that may contribute to differences in observed changes in IENFs include age at which diabetes 
is induced, method of induction, and sampling and quantitation approaches. In any case, there 
was no significant loss of cutaneous nerve fibers in our diabetic rats, indicating that LC changes 
in diabetes are not likely to be secondary to outright nerve degeneration.  
It is unclear how diabetes alters LC dynamics. One mechanism may involve altered 
production of granulocyte-macrophage colony-stimulating factor (GM-CSF). GM-CSF is 
necessary for LC proliferation and maturation (Heufler et al., 1988; Kingston et al., 2009). 
Diabetes reduces GM-CSF production in wounds by 50% (Fang et al., 2010), and delayed 
wound healing in diabetes is reversed by GM-CSF administration (Fang et al., 2010). Therefore, 
diminutions in GM-CSF may impair recruitment and maturation of LCs in diabetes. 
Collectively, this study shows that LCs are strongly influenced by aging and diabetes.  
Given that both aging and diabetes can be predisposing factors in development of cutaneous 
infections and ulcerations, our findings suggest that effects on dendritic cells may well play a 
role in the development of these pathologies.   
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Tables 
   
Table 1 Blood Glucose Levels and Body Weight at End of Experiment 
 
Glucose (mg/dL) 
Weight  
(grams) 
3 months 
Non-diabetic 
 
91 ± 5 
 
282 ± 8 
Diabetes, 4 wks 
6 months 
408 ± 34* 233 ± 10* 
Non-diabetic 120 ± 9 306 ± 4 
Diabetes, 16 wks 529 ± 22* 219 ± 11* 
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Table 1 Blood Glucose Levels and Body Weight at End of Experiment 
Blood glucose levels were significantly higher than controls after 4 and 16 weeks of diabetes. 
Glucose levels were significantly greater after 16 weeks of diabetes when compared to 4 weeks 
of diabetes. Body weight significantly decreased after four and 16 weeks of diabetes. Data is 
presented as mean ± SEM. *p<0.001 
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Figures 
Figure 1 
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Figure 1 Quantitative Analysis of Langerin+ LCs in the Rat Footpad  
The effect of age on LCs was quantified by comparing three month old non-diabetic (a) and 
diabetic animals (c) to six month old non-diabetic (b) and diabetic animals (d), respectively. The 
effect of STZ treatment on LCs was quantified by comparing non-diabetic animals at four and 16 
weeks post-treatment (a and b, respectively) to diabetic animals at four and 16 weeks post-
treatment (c and d, respectively). White arrows reveal longer processes on LCs in six month old 
non-diabetic animals. Bar graphs reflect LC density (e), size (f), and the % of epidermal area 
occupied by LCs (g) at 3 (4 weeks post-STZ) and 6 months (16 weeks post-STZ) of age. *: 
p=0.032 when compared to 4wk non-diabetic animals, #: p<0.001 when compared to 4 week 
non-diabetic animals, ##: p<0.001 when compared to 4 week diabetic animals, **: p<0.001 
when compared to 16 week non-diabetic animals  
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Figure 2 
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Figure 2 LC contribution to IENF values at 4 Weeks of diabetes 
Footpad sections were double-stained with a PGP9.5 (a and b) and langerin (c and d) antibody 
to identify IENFs and LCs, respectively. PGP9.5 and langerin images were merged (e and f) to 
display LC contribution to PGP9.5(+) IENFs in non-diabetic (a, c, and e) and diabetic animals 
(b, d, and f) at four weeks post-treatment. Open arrowhead designates PGP9.5+ LCs. Filled 
arrowheads mark an IENF that branches from dermal nerve bundle and enters epidermis. Thin 
arrow indicates PGP9.5+/Langerin+ that would be considered a PGP9.5+ IENF if langerin 
immunoreactivity was not considered. Closed arrow reflects PGP9.5-/Langerin+ LCs. Before 
langerin immunoreactivity was considered, IENF density was quantified (solid bars). After 
PGP9.5+ profiles that express langerin were excluded, PGP9.5+/langerin- IENFs were 
calculated (dashed bars). * p=0.024 as compared to non-diabetic PGP9.5+ IENF density 
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Figure 3 
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Figure 3 LC Contribution to IENF Values at 16 Weeks of diabetes 
Footpad sections from non-diabetic animals (a, c, and d) and diabetic animals (b, d, and f) were 
double-stained with PGP9.5 (a and b) and langerin (c and d) antibodies. Merged images (e and 
f) reveal LC contribution to IENF density by means of PGP9.5 expression. Closed arrow reflects 
PGP9.5-/Langerin+ LCs. Before langerin immunoreactivity was considered, IENF density was 
quantified (solid bars). After PGP9.5+ profiles that express langerin were excluded, 
PGP9.5+/langerin- IENFs were calculated (dashed bars). * p<0.001when compared to PGP9.5+ 
IENF density for 3 month old non-diabetic rats and ** p=0.005 when compared to 
PGP9.5+/langerin- IENF density for 3 month old non-diabetic rats 
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Electronic Material Legend 
Electronic Supplementary Material Movie 1 (S1).  Langerin Expression within LCs in the Non-
Diabetic Footpad at Four Weeks post-treatment.  3-D reconstruction of confocal images taken 
with a 100X objective from a footpad section double-stained with a langerin (red) antibody 
shows langerin is expressed within LCs.  
Electronic Supplementary Material Movie 2 (S2).  Langerin and PGP9.5 Immunoreactivity within 
LCs in the Non-Diabetic Footpad at 16 Weeks Post-Treatment.  Footpad section was 
immunostained with a PGP9.5 (green) langerin (red) antibody. 3-D reconstruction of confocal 
images taken with a 100X objective revealed PGP9.5 and langerin immunoreactivity in the 
soma and processes of LCs. Moreover, 3-D imaging reveals LCs are intricately intermingled 
between IENFs, and their PGP9.5+ processes often stretch towards the basement membrane. 
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Chapter 4: General Discussion 
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It is widely accepted that a bi-directional crosstalk exists between immune cells and 
nerves. The nervous system is capable of modulating immune cells through neuropeptide 
expression and this includes LCs. Data suggests many immune cells may be capable of 
regulating nerve fibers, possibly through pro-inflammatory cytokines and neurotrophic factor 
expression. However, it is unclear whether LCs influence nerves. As a result, the objective of 
this study was to determine whether LCs are necessary for maintaining IENFs and if so, is this 
newly discovered role altered by age or diabetes. If LCs are required for proper epidermal 
innervation, LCs may become a new target for developing drugs to achieve and maintain 
epidermal innervation.  
Langerhans cells are necessary for maintaining intraepidermal nerve fibers 
With the use of the Lang-DTR mouse model, this study showed LCs provide a 
substantial amount of support for IENFs. Results revealed LCs help maintain peptidergic IENFs 
in 1 month old mice. To determine whether LCs are influencing IENFs through neurotrophic 
factors, gene expression for common neurotrophic factors were examined. Results from 1 
month old mice showed LCs control roughly 75% and 90% of NGF and GDNF gene expression, 
respectively. This implies that LCs may be regulating peptidergic IENFs by manipulating NGF 
and GDNF expression. When cutaneous sensitivity was examined, data showed LC depletion 
increased mechanical sensitivity which was associated with peptidergic IENF loss. Since C 
fibers can detect mechanical stimuli (Teliban et al., 2011) and peptidergic IENFs are a subtype 
of C fibers, these data imply LCs provide trophic support for peptidergic C fibers that are 
essential for properly recognizing mechanical stimuli. Our data also supports previous studies 
that report allodynia can be associated with C fiber loss (Xiao et al., 2009) and neuropathy 
(Hovaguimian and Gibbons, 2011).  
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Research shows aging can be associated with a reduction in immune cells and 
innervation in the skin (Belsito et al., 1989; Goransson et al., 2004). Therefore, it is reasonable 
to hypothesize that the newly discovered relationship between LCs and IENFs may be altered in 
older mice. As a result, LCs and IENFs were examined in older mice in addition to whether age 
altered LCs role in IENF maintenance. LCs and IENFs were reduced with aging. Since the first 
study showed LCs are necessary for maintaining IENFs, it is possible that a reduction in IENFs 
may be due to a reduction in LC. A reduction in LC-IENF interaction may help explain why aging 
is linked to increased susceptibility to infection and delayed wound healing (Pittman, 2007; 
Ongradi et al., 2009; Prakash and Davis, 2010).  
Quantification of IENF subtypes revealed the subtype influenced changed from 
peptidergic to non-peptidergic with age. Data from 1 month old mice showed IENF degeneration 
was associated with reduced neurotrophin expression; this was not the case for older mice. The 
lack of change in neurotrophic factor expression indicates that LCs do not help maintain IENFs 
through neurotrophic factor expression in older mice and that another pathway is used. 
Although more studies are needed to determine how LCs provide trophic support in older mice, 
these data provide a new function for LCs.  
Collectively, the first study reveals LCs play a fundamental role in maintaining epidermal 
innervation. In addition, inconsistent changes in neurotrophic factor expression with age suggest 
the process by which LCs provided support involves multiple pathways. Despite this 
conundrum, our study provides evidence that the relationship between LCs and epidermal nerve 
fibers is a two-way street and that future studies are needed to determine the mechanism(s) 
LCs employ to help maintain IENFs in older mice. Information from this study suggests that a 
reduction in LC status may be an early indicator of small fiber neuropathy associated with 
74 
 
Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy, diabetes, 
HIV/AIDS, and alcoholism. 
 
Diabetes reduces Langerhans cells but not intraepidermal nerve fibers 
DM is often associated with delayed wound healing and chronic severe cutaneous 
infections. Although many factors such as a suppressed immune system and small fiber 
neuropathy are known to contribute to the severity of these complications, little is known about 
DM’s effect on LCs and their relationship with IENFs in the skin. Since results showed LCs 
provide neurotrophic support, it is possible that a reduction in LCs caused by diabetes could 
lead to a reduction in IENFs. The purpose of the second study was to examine whether STZ-
induced diabetes in the rat causes a reduction in LCs which could lead to IENF degeneration.  
LCs and IENFs were examined after 4 and 16 weeks of STZ-induced diabetes. Due to 
the fact that rats were three months older after 16 weeks of STZ-induced diabetes and that age 
can influence LCs and IENFs, it was necessary to examine age as a modulator of LCs and 
IENFs. LC proliferation and maturation increased in older rats. This was different from what was 
observed in mice. This may be because mice were allowed to age more (~9 months) than rats 
(3 months). Therefore, it may have been too early to observe aging-induced LC reduction in the 
rat. Also, it is unclear whether results are due to a difference in species.  
IENF density decreased with aging rats. Since we showed LCs are necessary for IENF 
maintenance, was reasonable to conclude that a reduction in IENFs was due to a reduction in 
LCs. However, this hypothesis does not hold true for the rats in this study. In this case, IENF 
loss was associated with an increase in LC status. This suggests that the relationship between 
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LCs and IENFs in the rat may not be similar to that of the mouse. However, since aged mice 
were roughly 6 months older than the rats, it is not reasonable to disregard the potential role 
LCs play in maintaining IENFs in rat skin. For the most part, our data agrees with studies that 
report a decrease in LCs and IENFs with aging (Bhushan et al., 2002; Cumberbatch et al., 
2002; Goransson et al., 2004; Lauria et al., 2010). 
 Data showed STZ-induced diabetes did in fact reduce LC proliferation and maturation. 
Moreover, this effect was more apparent with a longer duration of hyperglycemia. Analysis of 
IENFs revealed IENF status did not change with STZ-induced diabetes. These data imply that 
LCs are more sensitive to hyperglycemia than IENFs after 16 weeks of streptozotocin-induced 
diabetes in the rat. Although small fiber neuropathy was not observed, we cannot rule out that 
neuropathy could occur after a longer period of hyperglycemia and that a reduction in LCs 
occurs prior to IENF loss. Previous studies report changes in IENFs can modulate LC density. 
Since diabetes did not alter IENFs, this data also show that a reduction in LCs is more likely a 
direct effect of diabetes than changes in IENFs. Altogether, this data indicate a reduction in LCs 
by diabetes may lead to a reduction in immunosurveillance. Decreased immunosurveillance 
could potentially lead to increased susceptibility to severe infections.  
  
Conclusion 
These data show LCs play an essential role in maintaining IENF density in mice. As 
animals age, the fiber subtype influenced by LCs switches from peptidergic to non-peptidergic 
IENFs. LCs provide support for IENFs through NGF and GDNF in young mice. However, the 
mechanism by which LCs support IENFs is altered with age which suggests this process 
includes multiple pathways. In addition, LCs help maintain proper mechanical sensitivity in the 
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skin through regulating peptidergic C fibers. Similar to previous studies, aging is associated with 
a reduction in LCs and IENFs in the mouse. Despite conflicting results with LCs in the rat, a 
reduction in IENFs in the mouse may be due to a reduction in LCs. In a STZ-induced diabetic 
environment, LC reduction precedes IENF degeneration. This may imply that after a certain 
amount of LC reduction, IENF degeneration occurs in the rat. Altogether, this suggests that 
changes in LC status may be an early indicator and contributor to abnormal innervation and 
sensitivity associated with atopic dermatitis, psoriasis, eczema, and various forms of small fiber 
neuropathy.  
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